A detailed history of Grove Bank & Trust transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 8 shares of MEDP stock, worth $4,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$4,720
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 10, 2025

SELL
$277.23 - $315.28 $5,267 - $5,990
-19 Reduced 70.37%
8 $2,000
Q1 2025

Apr 17, 2025

BUY
$304.69 - $360.97 $5,484 - $6,497
18 Added 200.0%
27 $8,000
Q4 2024

Jan 16, 2025

BUY
$308.93 - $363.58 $2,780 - $3,272
9 New
9 $2,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $18.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.